Showing 561-580 of 646 for: Cochrane Systematic Reviews > Psychiatric and substance abuse 
- Smoking cessation for chronic obstructive pulmonary disease
Cochrane Systematic Reviews, 12-Nov-2012
Smoking cessation is the most important treatment for smokers with chronic obstructive pulmonary disease (COPD), but little is known about the effectiveness of different smoking cessation interventions for this particular group of patients.
- Snoezelen for dementia
Cochrane Systematic Reviews, 7-Oct-2008
Snoezelen, multi-sensory stimulation, provides sensory stimuli to stimulate the primary senses of sight, hearing, touch, taste and smell, through the use of lighting effects, tactile surfaces, meditative music and the odour of relaxing essential oils. The
- Social norms information for alcohol misuse in university and college students
Cochrane Systematic Reviews, 16-Dec-2015
Drinking is influenced by youth perceptions of how their peers drink. These perceptions are often incorrect, overestimating peer drinking norms. If inaccurate perceptions can be corrected, young people may drink less.
- Social skills groups for people aged 6 to 21 with autism spectrum disorders (ASD)
Cochrane Systematic Reviews, 12-Sep-2013
Since autism was first described, major difficulties in social interaction have been a defining feature of individuals with autism spectrum disorders (ASD). Social skills groups are a common intervention for individuals with ASD. Although a frequently rec
- Social skills training for Attention Deficit Hyperactivity Disorder (ADHD) in children aged 5 to 18 years
Cochrane Systematic Reviews, 9-Nov-2011
Attention Deficit Hyperactivity Disorder (ADHD) in children is associated with hyperactivity and impulsitivity, attention problems, and difficulties with social interactions. Pharmacological treatment may alleviate symptoms of ADHD but seldom solves diffi
- Specialist breast care nurses for supportive care of women with breast cancer
Cochrane Systematic Reviews, 18-Jun-2008
Breast Care Nurses (BCNs) are now established internationally, predominantly in well resourced healthcare systems. The role of BCNs has expanded to reflect the diversity of the population in which they work, and the improvements in survival of women with
- Speech and language therapy interventions for children with primary speech and language delay or disorder
Cochrane Systematic Reviews, 21-May-2015
It is thought that approximately 6% of children have speech and language difficulties of which the majority will not have any other significant developmental difficulties. Whilst most children's difficulties resolve, children whose difficulties persist in
- Speech and language therapy to improve the communication skills of children with cerebral palsy
Cochrane Systematic Reviews, 1-Mar-2016
The production of speech, language and gesture for communication is often affected by cerebral palsy. Communication difficulties associated with cerebral palsy can be multifactorial, arising from motor, intellectual and sensory impairments. Children with
- Sports and games for post-traumatic stress disorder (PTSD)
Cochrane Systematic Reviews, 10-Nov-2009
Traumatic experiences evoke emotions such as fear, anxiety and distress and may encourage avoidance of similar situations in the future. For a proportion of those exposed to a traumatic event, this emotional reaction becomes uncontrollable and can develop
- St John's wort for major depression
Cochrane Systematic Reviews, 27-Jul-2009
In some countries extracts of the plant Hypericum perforatum L. (popularly called St. John's wort) are widely used for treating patients with depressive symptoms.
- Stabilisation splint therapy for temporomandibular pain dysfunction syndrome
Cochrane Systematic Reviews, 4-Jan-2016
Pain dysfunction syndrome (PDS) is the most common temporomandibular disorder (TMD). There are many synonyms for this condition including facial arthromyalgia, TMJ dysfunction syndrome, myofacial pain dysfunction syndrome, craniomandibular dysfunction and
- Statins for the prevention of dementia
Cochrane Systematic Reviews, 4-Jan-2016
This is an update of a Cochrane review first published in 2001 and then updated in 2009. Vascular risk factors including high cholesterol levels increase the risk of dementia due to Alzheimer's disease and of vascular dementia. Some observational studies
- Statins for the treatment of dementia
Cochrane Systematic Reviews, 2-Jul-2014
The use of statin therapy in established Alzheimer's disease (AD) or vascular dementia (VaD) is a relatively unexplored area. In AD, ß-amyloid protein (Aß) is deposited in the form of extracellular plaques and previous studies have determined Aß generatio
- Stimulant laxatives for constipation and soiling in children
Cochrane Systematic Reviews, 16-Jun-2008
Constipation is extremely common in childhood and may lead to overflow soiling/encopresis. Standard treatment of the more severe case is to empty the bowels of impacted faeces by the use of oral or rectal laxatives and then maintain regular bowel movement
- Strategies for managing sexual dysfunction induced by antidepressant medication
Cochrane Systematic Reviews, 16-Apr-2013
Sexual dysfunction (including altered sexual desire, orgasmic and ejaculatory dysfunction, erectile and other problems) is a relatively common side effect of antidepressant medication. These sexual side effects may compromise a person's lifestyle and resu
- Subjective barriers to prevent wandering of cognitively impaired people
Cochrane Systematic Reviews, 29-Mar-2009
People with dementia often wander, at times putting themselves at risk and presenting challenges to carers and institutional staff. Traditional interventions to prevent wandering include restraint, drugs and locked doors. Cognitively impaired people may r
- Sulpiride augmentation for schizophrenia
Cochrane Systematic Reviews, 18-Jan-2012
Sulpiride may be used in combination with other antipsychotic drugs in the hope of augmenting effectiveness – especially for those whose schizophrenia has proved resistant to treatment.
- Sulpiride for schizophrenia
Cochrane Systematic Reviews, 17-Oct-2012
The antipsychotic drug sulpiride was formulated over 20 years ago and was marked as having a low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharma
- Sulpiride versus placebo for schizophrenia
Cochrane Systematic Reviews, 7-Apr-2014
Sulpiride is a relatively old antipsychotic drug reputed to have a low incidence of adverse effects and an effect on the negative symptoms of schizophrenia. This relatively inexpensive antipsychotic drug has a similar neuropharmacological profile to sever
- Supported housing for people with severe mental disorders
Cochrane Systematic Reviews, 9-Nov-2010
There has been a significant reduction in the number of people with severe mental illness who spend extended periods in long-stay hospitals. District health authorities, local authorities, housing associations and voluntary organisations are jointly expec
